CD4+-T-cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 10, 2000, Pages 2653-2658

  Mizutani, S ^a   Endo, M ^a   Ino Ue, T ^a   Kurasawa, M ^a   Uno, Y ^a   Saito, H ^a   Onogi, K ^a   Kato, I ^a   Takesako, K ^a  

^a TAKARA SHUZO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FREUND ADJUVANT;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL WALL; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTOPLAST; SPLEEN CELL; SYSTEMIC DISEASE; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CANDIDIASIS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNIZATION; LYMPHOCYTE DEPLETION; MEMBRANES; MICE; MICE, INBRED BALB C; SPLEEN; SUBCELLULAR FRACTIONS;

EID: 0033797846     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.10.2653-2658.2000     Document Type: Article

References (20)

1. + lymphocytes in protective immunity to systemic Candida albicans infection in mice
2. T cell subsets and IFN-γ production in resistance to systemic candidosis in immunized mice
3. Candidiasis in the transplant patient
4. Colorimetric method for determination of sugars and related substances
5. Systemic candidiasis in mice immunized with Candida albicans ribosomes
6. A cell surface/plasma membrane antigen of Candida albicans
7. Chemical definition of an epitope/adhesin molecule on Candida albicans
8. Systemic candidiasis in cancer patients
9. A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice
10. Phase I trial of recombinant human macrophage colony-stimulating factor in patients with invasive fungal infections
11. The GTP-binding Sar1 protein is localized to the early compartment of the yeast secretory pathway
12. Immunity to Candida albicans
13. Th1 and Th2 cytokine secretion patterns in murine candidiasis: Association of Th1 responses with acquired resistance
14. + subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance
15. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
16. Cell wall components of Candida albicans as immunomodulators: Induction of natural killer and macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions
17. Immune responses elicited by vaccinations with Candida albicans ribosomes in cyclophosphamide treated animals
18. Lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein constituents of Candida albicans
19. Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of IL-6 and tumour necrosis factor-alpha (TNF-α) by MP-F2-stimulated PMNL from HIV-infected subjects
20. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus